BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21928351)

  • 1. KLF6/Sp1 initiates transcription of the tmsg-1 gene in human prostate carcinoma cells: an exon involved mechanism.
    Gong M; Yu W; Pei F; You J; Cui X; McNutt MA; Li G; Zheng J
    J Cell Biochem; 2012 Jan; 113(1):329-39. PubMed ID: 21928351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transcriptional activation of TMSG-1 by complex of KLF6 and Sp1].
    Gong MZ; You JF; Pei F; Cui XL; Li G; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):542-8. PubMed ID: 22169644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
    Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):404-7. PubMed ID: 19024511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of tumor metastasis suppressor gene 1 suppresses proliferation and invasion, but enhances apoptosis of human breast cancer cells MDA-MB-231 cells].
    Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):672-6. PubMed ID: 18194600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of a novel tumor metastasis suppressor gene LASS2/TMSG1 promotes invasion of prostate cancer cell in vitro through increase of vacuolar ATPase activity.
    Xu X; You J; Pei F
    J Cell Biochem; 2012 Jul; 113(7):2356-63. PubMed ID: 22573553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function.
    Britschgi A; Trinh E; Rizzi M; Jenal M; Ress A; Tobler A; Fey MF; Helin K; Tschan MP
    Oncogene; 2008 Sep; 27(43):5706-16. PubMed ID: 18521079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
    Chen CH; Huang PH; Chu PC; Chen MC; Chou CC; Wang D; Kulp SK; Teng CM; Wang Q; Chen CS
    J Biol Chem; 2011 Mar; 286(12):9968-76. PubMed ID: 21282102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
    Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
    Le Mée S; Fromigué O; Marie PJ
    Exp Cell Res; 2005 Jan; 302(1):129-42. PubMed ID: 15541732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
    Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
    Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Sp1/Sp3 in the activation of the GATA-1 erythroid promoter in K562 cells.
    Hou CH; Huang J; He QY; Zhang CN; Zhang XJ; Qian RL
    Cell Res; 2008 Feb; 18(2):302-10. PubMed ID: 18195733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
    Jiang JG; Chen Q; Bell A; Zarnegar R
    Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.
    Rubinstein M; Idelman G; Plymate SR; Narla G; Friedman SL; Werner H
    Endocrinology; 2004 Aug; 145(8):3769-77. PubMed ID: 15131018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the human pregnancy-specific glycoprotein PSG-5 promoter by KLF4 and Sp1.
    Blanchon L; Nores R; Gallot D; Marceau G; Borel V; Yang VW; Bocco JL; Lémery D; Panzetta-Dutari G; Sapin V
    Biochem Biophys Res Commun; 2006 May; 343(3):745-53. PubMed ID: 16563348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP1 regulates a human SNAP-25 gene expression.
    Cai F; Chen B; Zhou W; Zis O; Liu S; Holt RA; Honer WG; Song W
    J Neurochem; 2008 Apr; 105(2):512-23. PubMed ID: 18194215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers.
    Chiam K; Ryan NK; Ricciardelli C; Day TK; Buchanan G; Ochnik AM; Murti K; Selth LA; ; Butler LM; Tilley WD; Bianco-Miotto T
    Prostate; 2013 Jan; 73(2):182-93. PubMed ID: 22782870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.